Abgenix

Fremont, United States Founded: 1996 • Age: 30 yrs Acquired By Amgen
Fully human therapeutic antibodies for cancer and inflammation are discovered.
Request Access

About Abgenix

Abgenix is a company based in Fremont (United States) founded in 1996 was acquired by Amgen in December 2005.. Abgenix has completed 1 acquisition, including ImmGenics Pharmaceuticals. Abgenix offers products and services including Pancreatic Cancer Drugs, Zika Virus Vaccines, and Cancer Treatments. Abgenix operates in a competitive market with competitors including BeiGene, Moderna, Incyte, Regeneron Pharmaceuticals and Mereo BioPharma, among others.

  • Headquarter Fremont, United States
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Healthcare Products & Supplies
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
  • Acquired by
    Amgen

    (Dec 14, 2005)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Abgenix

Abgenix offers a comprehensive portfolio of products and services, including Pancreatic Cancer Drugs, Zika Virus Vaccines, and Cancer Treatments. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Drugs that block growth of pancreatic cancer cells

Vaccines aimed at fighting Zika virus infections

Treatments for various cancers including pancreatic types

Funding Insights of Abgenix

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Abgenix

Abgenix has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Amgen. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Developer of pharmaceutical products for treating multiple diseases
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Abgenix

Abgenix has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ImmGenics Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Technology for antibody drug discovery.
1993
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Abgenix

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Abgenix Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Abgenix

Abgenix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BeiGene, Moderna, Incyte, Regeneron Pharmaceuticals and Mereo BioPharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Targeted and immune-oncology drugs for cancer treatment are developed.
domain founded_year HQ Location
mRNA-based therapeutics for diseases including cancer and infections are developed.
domain founded_year HQ Location
Small molecules are developed for cancer and skin disease treatments.
domain founded_year HQ Location
Antibodies are developed for treating cancer, eye, and inflammatory diseases.
domain founded_year HQ Location
Therapeutics for cancer and rare diseases are developed.
domain founded_year HQ Location
ALX Oncology is focused on advancing cancer treatment therapies.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Abgenix

Frequently Asked Questions about Abgenix

When was Abgenix founded?

Abgenix was founded in 1996.

Where is Abgenix located?

Abgenix is headquartered in Fremont, United States. It is registered at Fremont, California, United States.

What does Abgenix do?

Abgenix was a biopharmaceutical company focused on the discovery of fully human therapeutic antibodies for cancer and inflammatory diseases. Its products include Panitumumab, co-developed by Amgen is an IgG2 MAb which targets the epidermal growth factor receptor (EGFr), a protein that plays a role in cancer cell signaling. Its other product Denosumab is designed to target RANK Ligand, a protein that acts as the primary signal to promote bone removal. It claims to have potential in the treatment of a broad range of bone loss conditions including osteoporosis, treatment-induced bone loss, bone metastases, multiple myeloma, and rheumatoid arthritis. In December 2005, Amgen acquired Abgenix for around 2.2B.

Who are the top competitors of Abgenix?

Abgenix's top competitors include Moderna, BeiGene and Strand Therapeutics.

What products or services does Abgenix offer?

Abgenix offers Pancreatic Cancer Drugs, Zika Virus Vaccines, and Cancer Treatments.

How many acquisitions has Abgenix made?

Abgenix has made 1 acquisition, including ImmGenics Pharmaceuticals.

Who are Abgenix's investors?

Abgenix has 1 investor. Key investors include Amgen.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available